American Well Q3 revenue beats estimates on subscriptions, AMG

Overview

• US SaaS healthcare platform's Q3 revenue rose and beat analyst expectations

• Company posted Q3 net loss of $11.0 mln

• Company raised 2026 revenue and adjusted EBITDA outlook

Outlook

• Amwell raises 2026 revenue outlook to $204 mln-$206 mln from $200 mln-$205 mln

• Amwell raises 2026 adjusted EBITDA outlook to ($8) mln-($7) mln from ($9) mln-($7) mln

• Company expects 2026 AMG visits between 1.32 mln and 1.37 mln

Result Drivers

• SUBSCRIPTION AND VISIT REVENUE - Co said Q3 revenue was driven by subscription revenue of $23.9 mln and Amwell Medical Group visit revenue of $23.7 mln

• MEMBER ENGAGEMENT - Co said activating more members and simplifying their experience contributed to Q3 results

Company press release:

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 8 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the healthcare facilities & services peer group is "buy."

• Wall Street's median 12-month price target for American Well Corporation is $12.00, about 4.2% below its November 2 closing price of $12.52

Reuters Recommended Reads

• Nov 2 - Waystar Q3 revenue, adjusted profit beat estimates on subscription growth

• Nov 2 - HealthStream Q3 revenue, adjusted EBITDA beat estimates; raises 2026 outlook

• Nov 3 - Varonis Q3 revenue rises 17%, beats analyst expectations

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)